Cronos Unveils Next Part of Its Asia if not Global Cannabis Strategy
Marguerite Arnold
February 21st, 2018
Policy
With eyes on Europe right now as new announcements and deals were announced almost weekly during the first six weeks of the year, it is clear that the EU is not the only centre of all things international and cannabinoid related.
Australian development, pumped in part also by the money and expertise of the largest Canadian firms, is also proceeding apace.
In the first week of February, as the world suddenly realized that the Italian military were getting out of the pot producing business, Cronos Group unveiled a massive Australian joint venture with Australian company NewSouthern Capital Pty Ltd to launch Cronos Australia Pty Ltd. The group has just announced the first phase of an AUS$10 million (USD$8 million) production facility to meet demand in both Australia and other parts of Asia.
It is a prescient move indeed, coming just weeks before Benjamin Netanyahu put Israel’s about-to-be approved export plans on ice after a request from Donald Trump. In fact, Australian cannabis firms and the Canadians they are partnering with, appear to be the immediate beneficiary of this latest anti-cannabis salvo from the White House. Cronos specifically, had just established as of September 2017, a strategic joint venture with Kibbutz Gan Shmuel in Israel for the production of cannabis and its export to 35 countries and other parts of Asia.
The Evolving Cannabinoid Export Market Map
Australia is going to be a critical launching point for the Southern Hemispheric cannabis revolution. Not to mention a valuable source of raw product for firms participating in the global one. The country represents a large, domestic, English-speaking audience, but producers Down Under are not shy about their aspirations internationally.
That starts with the rest of Asia. With Israel out of the picture on this front, it sets up Canadian-Australian partnerships of the kind that are now forming in fact, to establish a lock-up on international distribution relationships for whole countries.
A look at who else has blazed a path in Australia recently, only bears this out. The largest Canadian LPs, including Canopy and Aurora, have also entered the market via similar partnerships.
However, it does not stop there. It is clear that as much as Canadians are leapfrogging into the country, these Australian firms are right in the thick of Euro action, back into (particularly) Germany and Eastern Europe.
Cronos, in fact, made news last fall by entering into a distribution deal in Germany that puts its product in over 12,000 pharmacies around the country.
There is a clear connection to what is going on in Australia, Canada and Germany, right now, in other words, and Cronos is right in the middle of it.
The Race To Source Cheap, Abundant, High Quality Crops
As the ongoing drama about exports in Israel demonstrate, those firms and countries who position themselves in the evolving medical marijuana source game – globally – will be able to lock up world-wide distribution rights for at least the next generation. If not hold a monopoly position in the most valuable cannabis markets as they transition, inevitably, to recreational use.
In the meantime, however, it means that a handful of firms (less than 10), all with Canadian roots or connections, can now source the cheapest cannabis on the planet, from all the major centres of production now in existence or about to be in construction.
For Canadians, Danes, Australians and Germans (among a few others), this means that medical crops will come from home first. But in the face of lagging production, or even shortages, cheaper markets will inevitably begin to supply, where it is cost efficient, some qualities of oil, extract and actual pharmacized cannabinoids to such western and more wealthy markets.
So what does this newest announcement really say about Cronos? It is a firm indisputably in the global club of major cannabis producers. And it is beyond doubt that Australian grown cannabis may well end up (at least) in a pharmacy near you.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Marguerite Arnold
Marguerite Arnold is a veteran investigative and markets journalist, American expat and author. She has covered the cannabis industry from Germany for the last six years. Her book, Green: The First Year of Modern American Cannabis Reform about the American market in 2014 has just been republished as she is writing the sequel about Europe and the global revolution this year. Green II: Spreading Like Kudzu will be published in 2020. She is also a noted technologist and entrepreneur. Her blockchain-based digital prescription platform MedPayRx was just shortlisted by the German Ministry of Health as one of the "Top 20" use cases for blockchain in healthcare.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
The producers of O’ Cannabiz have decades of experience producing national-profile events and creating global connections between business communities in the arts, broadcasting, media and technology. They have organized trade summit initiatives with governments around the world. And they have worked closely with sponsors in all levels of Canadian government.
Matthew Nordgren is an ambitious executive, dedicated philanthropist, and accomplished athlete who brings a unique passion to creating strategic alliances. He has breadth and depth of experience in finance, corporate development, and capital sourcing, as well as in building highly motivated teams of skilled professionals. In 2005, Mr. Nordgren received his education at the University […]
ManifestSeven (M7), formerly known as MJIC, is the first integrated omnichannel platform for legal cannabis, merging compliant distribution with a retail superhighway.
Segra is a plant micropropagation (also known as “tissue culture”) company specializing in cannabis. Segra is focused on producing standardized cannabis plantlets on an industrial scale to meet global demand for clean, disease-free starting materials. The Company is currently developing cannabis micropropagation nurseries to serve large-scale producers in Canada and the US (California). In Canada, […]
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
